AMS

Business Context and Reporting Period

Company: American Shared Hospital Services
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2001
Business Overview: The Company provides Gamma Knife units to medical centers through fee-per-use contracts and revenue-sharing agreements. As of September 30, 2001, the Company operated 12 Gamma Knife units across 11 states, an increase from 9 units in the prior year. The Company also holds a majority interest in GK Financing, LLC, and has two startup businesses: OR21 and MedLeader.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Medical services revenue increased by $514,000 (20.3%) for the three months and $2,022,000 (30.1%) for the nine months ended September 30, 2001, compared to the prior year. This growth is attributed to the addition of three new Gamma Knife units and a 4% revenue increase at existing centers.
• Net Income Decline: Despite revenue growth, net income decreased to $256,000 (Q3) and $859,000 (9 months) from $424,000 and $951,000 in the prior year periods. The primary driver was the commencement of a 40% income tax provision in the second quarter of 2001, as net operating loss carryforwards were exhausted.
• Expense Increases: Total costs of operations rose due to higher maintenance/supplies (warranty expirations), depreciation (new units), and interest expense (financing for new units). Selling and administrative costs increased due to investor relations, accounting fees, and startup development costs.
• Interest Income: Interest and other income decreased significantly ($97,000 for Q3; $243,000 for 9 months) due to lower interest rates on cash balances and a reduction in state tax refunds compared to the prior year.

Guidance, Outlook, and Risks

• Tax Outlook: Management expects to continue recording an estimated 40% income tax provision for the remainder of the fiscal year.
• Liquidity: The Company holds $11,549,000 in cash and cash equivalents. Management believes cash flow from operations and existing resources are adequate to meet scheduled debt obligations of approximately $7,212,000 due in the next 12 months.
• Capital Allocation: Cash decreased by $872,000 during the nine-month period due to deposits for future Gamma Knife purchases ($575,000), the payment of the first annual dividend ($361,000), and share/option repurchases ($595,000).
• Accounting Changes: The Company noted recent FASB pronouncements (SFAS 141, 142, 143, 144) regarding business combinations, goodwill, asset retirement obligations, and impairment. Management does not expect these to have a material effect on current results.
• Risks: No legal proceedings or defaults on senior securities were reported. The primary operational risk involves the profitability of minority-owned subsidiary GK Financing, which contributed to increased minority interest charges.

Investor Verification Checklist

• Tax Provision Impact: Verify the sustainability of the 40% tax rate and the exhaustion of net operating loss carryforwards.
• Debt Service Coverage: Confirm that operating cash flows remain sufficient to cover the $7.2 million in debt payments due within 12 months.
• Unit Utilization: Assess the revenue contribution and utilization rates of the three new Gamma Knife units added in 2001.
• Startup Viability: Review the progress and burn rate of the startup businesses OR21 and MedLeader, which incurred $164,000 in development costs for the nine-month period.
• Share Repurchases: Monitor the impact of ongoing share and option repurchases on outstanding share count and liquidity.